SK Hynix Investment Spurs Capacity Expansion

SK Hynix Investment in a $12.85 billion packaging plant reshapes HBM supply for AI data-center chips and could shift trader positioning in memory names.

April 22, 2026·2 min read
View all news articles
Flat vector of a chip module expanding to represent SK Hynix Investment and HBM packaging capacity for AI data centers.

KEY TAKEAWAYS

  • Announced a $12.85 billion P&T7 advanced-packaging investment to expand HBM capacity for AI data centers.
  • Q1 net profit rose 406% year over year with operating margin 72% and net margin 77%.
  • Construction starts April 2026; wafer testing Oct 2027; wafer-level packaging Feb 2028.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

SK Hynix Co. reported a record quarterly profit on April 22, 2026, driven by rising AI-memory prices and demand, alongside announcing a $12.85 billion investment in a new advanced-packaging plant to expand capacity for data-center chips.

P&T7 Advanced Packaging Facility

The company plans to build P&T7, an advanced-packaging plant dedicated to high-bandwidth memory (HBM) for AI data centers and Nvidia platforms. The facility will support mass production of a 192-gigabyte SOCAMM2 module for the Vera Rubin platform.

Located in the Heungdeok district of Cheongju, South Korea, P&T7 will be SK Hynix’s fifth packaging site, following M11, M12, M15, and M15X. The plant will feature about 60,000 square meters of wafer-level packaging across three floors and 90,000 square meters of wafer-test lines across seven floors, totaling roughly 150,000 square meters of cleanroom space. Construction is scheduled to start in April 2026, with wafer testing planned for October 2027 and wafer-level packaging for February 2028. The investment remains subject to change based on market conditions and company strategy.

Q1 Results and AI Memory Demand

SK Hynix reported first-quarter revenue of 52.6 trillion won, operating profit of 37.6 trillion won with a 72% margin, and net profit of 40.3 trillion won with a 77% margin. Net profit rose 406% year over year, reflecting stronger AI-memory sales and higher memory prices.

Management said it will align capital projects and product launches to secure supply amid accelerating AI memory demand, describing these efforts as essential for the emerging agentic AI era. The company also highlighted a complementary $3.87 billion packaging project in Indiana targeting next-generation HBM4E and HBM5 production, with mass production expected in the second half of 2028. It warned that chip shortages could persist through 2030.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.